Skip to main content

Table 4 Showing the sites of distant metastases by CT versus PET-CT

From: The added value of18F-FDG PET/CT in staging non-small cell lung cancer

 

CT

PET

P. diff.

P. agree.

Kappa

No.

%

No.

%

Contalateral nodules

Positive

9

22.5

3

7.5

0.060

0.001

0.437 (0.0932 to 0.780)

Negative

31

77.5

37

92.5

Pleural effusion

Positive

10

25.0

3

7.5

0.034

0.083

0.217 (− 0.0999 to 0.535)

Negative

30

75.0

37

92.5

Liver mets

Positive

7

17.5

5

12.5

0.531

0.000

0.805 (0.546 to 1.000)

Negative

33

82.5

35

87.5

Adrenal mets

Positive

3

7.5

4

10.0

0.692

0.000

0.844 (0.545 to 1.000)

Negative

37

92.5

36

90.0

Bone mets

Positive

7

17.5

13

32.5

0.121

0.000

0.612 (0.348 to 0.876)

Negative

33

82.5

27

67.5

Intramuscular mets

Positive

1

2.5

4

10.0

0.166

0.002

0.375 (− 0.156 to 0.906)

Negative

39

97.5

36

90.0

Brain mets

Positive

2

5.0

2

5.0

1.000

0.000

1.000 (1.000 to 1.000)

Negative

38

95.0

38

95.0

Abdominal LNs

Positive

3

7.5

7

17.5

0.176

0.000

0.553 (0.181 to 0.925)

Negative

37

92.5

33

82.5

Pancreatic mets

Positive

1

2.5

1

2.5

1.000

0.000

1.000 (1.000 to 1.000)

Negative

39

97.5

39

97.5